The results showed that both the phospho-ERK1/2 and total ERK1/2 protein levels were markedly reduced in HCK−/− LSCs or human AML cell lines compared to controls (Fig. 6b). The gene discussed is MAPK3; the disease is acute myeloid leukemia.